Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
gilead sciences
kymriah
life sciences
medicare
national blog main
national top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
yescarta
3
×
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
drug prices
immuno-oncology
immunotherapy
indiana blog main
indiana top stories
kite pharma
national
new york blog main
new york top stories
novartis
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
acquisition
What
drug
acquisitions
adding
airport
albert
annual
apocalypse
beds
bets
biggest
bio
boost
bourla
cancer
celgene
ceo
company
crispr
days
expensive
fallout
far
future
gilead
gone
home
imports
j.p
jpm
maker
maps
measured
million
notes
patients
paying
pfizer
pfizer’s
pipeline
price
Language
unknown
Current search:
yescarta
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
